BioNTech

Mayo Clinic pancreatic cancer vaccine clinical trial

3 clusters · 10 sources · last updated 1 day ago

Latest: BioNTech and Camupepimut report clinical trial results for cancer treatments

Researchers at Mayo Clinic have reported promising results from a phase 2 clinical trial of an investigational, ‘off the shelf’ vaccine designed to target KRAS mutations in pancreatic ductal adenocarcinoma. The study, pu

SAP product strategy and financial growth

7 clusters · 28 sources · last updated 2 days ago

Latest: SAP expands AI transformation guidance through Max Success Plan

SAP is undergoing a strategic shift focused on artificial intelligence and cloud expansion. The German-speaking SAP User Group (DSAG) has advocated for clearer AI governance guidelines and greater flexibility in operatin

Scientific reviews of mRNA technology safety

2 clusters · 6 sources · last updated 4 days ago

Latest: Researchers examine mRNA vaccine persistence and lipid nanoparticle effects

Scientific literature reviews published in late October 2026 have evaluated the safety and toxicological profiles of modified mRNA technology. A review in the Journal of Toxicology examined research from 2020 to 2026,

Moderna and Merck melanoma vaccine clinical trials

19 clusters · 558 sources · last updated 5 days ago

Latest: BioNTech and Moderna face mixed clinical and market outlooks

Moderna and Merck (MSD) have reported positive Phase 3 clinical trial results for intismeran autogene (V940), an experimental personalized mRNA cancer vaccine. The INTerpath-001 trial, which administered the vaccine alon

mRNA technology and personalized cancer vaccine research

3 clusters · 117 sources · last updated 6 days ago

Latest: Merck and Moderna mRNA vaccine reduces melanoma recurrence risk

Recent medical research highlights significant progress in using messenger RNA (mRNA) technology to develop personalized cancer vaccines. These vaccines utilize a patient’s specific tumor mutations or neoantigens to trai

Advances and challenges in mRNA and immunotherapy trials

11 clusters · 25 sources · last updated 12 days ago

Latest: Immunotherapy advancements show promise in treating colorectal and melanoma cancers

Cancer immunotherapy is evolving through personalized mRNA vaccines and cellular therapies. Recent breakthroughs include a platform generating T-cells from hematopoietic stem cells, which offers a ready-to-use alternativ

BioNTech BNT113 clinical trial results

2 clusters · 6 sources · last updated 19 days ago

Latest: BioNTech BNT113 fails first clinical endpoint in head and neck cancer trial

BioNTech reported that its experimental mRNA cancer immunotherapy, BNT113, failed to meet the primary endpoint in a combined Phase 2/3 clinical trial known as AHEAD-MERIT. The study evaluated the combination of BNT113 an

European biotechnology innovation and funding gaps

2 clusters · 3 sources · last updated 21 days ago

Latest: DACH region life sciences sector faces translation and funding gaps

The European and DACH (Germany, Austria, and Switzerland) biotechnology sectors are facing significant structural challenges regarding innovation, talent, and capital. Reports indicate a critical gap in the ability to tr

Global corporate and market sector trends

2 clusters · 13 sources · last updated 22 days ago

Latest: Global markets face regulatory fees for UBS and shifting analyst targets

Global financial markets continue to show varied activity across the energy, technology, defense, and consumer sectors. In the energy sector, TotalEnergies expanded its renewable footprint through a $1.2 billion joint v

African pursuit of economic and strategic sovereignty

2 clusters · 3 sources · last updated 23 days ago

Latest: African economic growth linked to entrepreneurship and strategic autonomy

African nations are pursuing sovereignty and strategic autonomy through diverse international partnerships and domestic economic reforms. Initial efforts focus on securing control over technology, data, and essential ind

BioNTech strategic transition to oncology focus

2 clusters · 55 sources · last updated 28 days ago

Latest: BioNTech focuses on oncology pipeline amid strategic transition

BioNTech is undergoing a strategic transition from a pandemic-era vaccine manufacturer to a specialized oncology company. Following a decline in global demand for COVID-19 vaccines, the company announced the phased closu

Pancreatic cancer treatment and care advancements

2 clusters · 10 sources · last updated 28 days ago

Latest: Pancreatic cancer research and care models see new developments

Developments in pancreatic cancer treatment are focusing on both clinical immunotherapy breakthroughs and improved healthcare delivery models. Clinical research has highlighted the potential of cancer vaccines to train

BioNTech corporate developments and oncology expansion

2 clusters · 3 sources · last updated 28 days ago

Latest: BioNTech expands oncology pipeline amid various corporate insider stock sales

BioNTech CEO Ugur Sahin executed multiple stock sales in early September, selling 149,500 shares at prices between approximately $96.31 and $103.52 per share. These transactions were conducted under a pre-arranged Rule 1